152 results
8-K
EX-99.1
ACET
Adicet Bio Inc
14 May 24
Adicet Reports First Quarter 2024 Financial Results and Provides Business Updates
4:03pm
to commence a Phase 1 clinical trial to assess the safety and efficacy of ADI-001 in lupus nephritis in the second quarter of 2024. Preliminary data from … update on safety, efficacy and 6-month complete response data in MCL patients in the second half of 2024.
Financial Results for First Quarter 2024
8-K
EX-99.1
ACET
Adicet Bio Inc
10 May 24
Regulation FD Disclosure
6:09am
lymphocytes) Target has clinical safety experience CD70 is expressed on multiple solid and hematological cancers with limited expression in normal tissues … preclinically Robust efficacy maintained across multiple relevant tumor models of varying stringency Desirable preclinical safety profile with lower potential
8-K
ACET
Adicet Bio Inc
22 Apr 24
Regulation FD Disclosure
4:31pm
, its unique use of CD27-based targeting of CD70 and the potential potency, safety, durability, tolerability and efficacy of the product candidate … adequate safety and efficacy of Adicet’s product candidates, which would prevent, delay, or limit the scope of regulatory approval
8-K
EX-99.1
ACET
Adicet Bio Inc
22 Apr 24
Regulation FD Disclosure
4:31pm
and the potential potency, safety, durability, tolerability and efficacy of the product candidate; the Company’s expectations regarding regulatory filings … ; clinical studies may fail to demonstrate adequate safety and efficacy of Adicet’s product candidates, which would prevent, delay, or limit the scope
424B5
ee1lhrrr2 ygok45i5
22 Mar 24
Prospectus supplement for primary offering
4:12pm
8-K
EX-99.1
yzbtj4n59u0246l1
19 Mar 24
Adicet Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Company Progress
4:13pm
424B5
nwpany0kzyg
24 Jan 24
Prospectus supplement for primary offering
4:32pm
424B5
1qti vdmm9pyi
22 Jan 24
Prospectus supplement for primary offering
4:30pm
8-K
EX-99.1
ximbg6g
16 Jan 24
Regulation FD Disclosure
7:01am
8-K
EX-99.1
r21 oewkui0
4 Jan 24
Adicet Provides Corporate Update and Highlights Strategic Priorities for 2024
7:17am
8-K
xb906hnll7l gi
4 Jan 24
Adicet Provides Corporate Update and Highlights Strategic Priorities for 2024
7:17am
8-K
EX-99.1
0g91s zla9y3nzw0vpq2
8 Nov 23
Adicet Reports Third Quarter 2023 Financial Results and Provides Business Updates
4:12pm
8-K
EX-99.1
wdmx6rft4 33mi86in
9 Aug 23
Adicet Reports Second Quarter 2023 Financial Results and Provides Business Updates
4:17pm
8-K
EX-99.1
j2qpca c38
11 Jul 23
Adicet Announces Appointment of Katie Peng to the Board of Directors
8:32am
8-K
06ws sn9wmrp8
26 Jun 23
Regulation FD Disclosure
4:02pm